Sulejmani, O.; Grunewald, L.; Andersch, L.; Schwiebert, S.; Klaus, A.; Winkler, A.; Astrahantseff, K.; Eggert, A.; Henssen, A.G.; Schulte, J.H.;
et al. Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis. Cancers 2021, 13, 5489.
https://doi.org/10.3390/cancers13215489
AMA Style
Sulejmani O, Grunewald L, Andersch L, Schwiebert S, Klaus A, Winkler A, Astrahantseff K, Eggert A, Henssen AG, Schulte JH,
et al. Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis. Cancers. 2021; 13(21):5489.
https://doi.org/10.3390/cancers13215489
Chicago/Turabian Style
Sulejmani, Ornela, Laura Grunewald, Lena Andersch, Silke Schwiebert, Anika Klaus, Annika Winkler, Kathy Astrahantseff, Angelika Eggert, Anton G. Henssen, Johannes H. Schulte,
and et al. 2021. "Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis" Cancers 13, no. 21: 5489.
https://doi.org/10.3390/cancers13215489
APA Style
Sulejmani, O., Grunewald, L., Andersch, L., Schwiebert, S., Klaus, A., Winkler, A., Astrahantseff, K., Eggert, A., Henssen, A. G., Schulte, J. H., Anders, K., & Künkele, A.
(2021). Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis. Cancers, 13(21), 5489.
https://doi.org/10.3390/cancers13215489
